Bulletin
Investor Alert

Market Pulse Archives

April 23, 2021, 10:07 a.m. EDT

CDC committee to meet today to discuss J&J's COVID-19 shot

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    Johnson & Johnson (JNJ)

or Cancel Already have a watchlist? Log In

By Jaimy Lee

JNJ

A Centers for Disease Control and Prevention's advisory committee is scheduled to meet for a second time on Friday, April 23, to discuss rare safety concerns about Johnson & Johnson's /zigman2/quotes/201724570/composite JNJ +0.45% COVID-19 vaccine. Of the 6.8 million people in the U.S. who have received the J&J's shot, six women have been hospitalized with severe blood clots after receiving the vaccine. As a result, federal health officials recommended a "pause" in using the vaccine, a decision that was extended when the CDC's Advisory Committee on Immunization Practices met earlier this week. The emergency meeting is scheduled for 11 a.m. to 5 p.m. Eastern Time on April 23. It will be webcast to the public.

/zigman2/quotes/201724570/composite
US : U.S.: NYSE
$ 168.50
+0.76 +0.45%
Volume: 5.32M
May 7, 2021 4:00p
P/E Ratio
29.76
Dividend Yield
2.52%
Market Cap
$441.73 billion
Rev. per Employee
$613,918
loading...

Get news alerts on Johnson & Johnson — or create your own.
This Story has 0 Comments
Be the first to comment
More News In
Industries

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.